Anti-idiotypic antibodies in patients with monoclonal gammopathies: relation to the tumour load

Br J Haematol. 1991 May;78(1):66-70. doi: 10.1111/j.1365-2141.1991.tb04384.x.

Abstract

The production of anti-idiotypic antibodies from Epstein-Barr virus transformed peripheral blood lymphocytes was analysed in 12 patients with multiple myeloma and monoclonal gammopathy of undetermined significance. A low anti-idiotype production was found in patients with advanced disease (multiple myeloma stage III), whereas the production was high in patients with multiple myeloma stage I and monoclonal gammopathy of undetermined significance (MGUS) (P less than 0.01). The study supports the existence of an immunological network response in patients with monoclonal gammopathies.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Antibodies, Anti-Idiotypic / analysis*
  • Antibodies, Anti-Idiotypic / immunology
  • B-Lymphocytes / immunology*
  • Enzyme-Linked Immunosorbent Assay
  • Humans
  • Immunoglobulin A / isolation & purification
  • Immunoglobulin Fragments / isolation & purification
  • Immunoglobulin G / isolation & purification
  • Immunoglobulin M / analysis*
  • Lymphocyte Activation / immunology
  • Middle Aged
  • Multiple Myeloma / immunology
  • Multiple Myeloma / pathology
  • Neoplasm Staging
  • Paraproteinemias / immunology*
  • Paraproteinemias / pathology

Substances

  • Antibodies, Anti-Idiotypic
  • Immunoglobulin A
  • Immunoglobulin Fragments
  • Immunoglobulin G
  • Immunoglobulin M